|Bid||22.80 x 0|
|Ask||22.85 x 0|
|Day's Range||22.59 - 23.06|
|52 Week Range||12.96 - 38.33|
|Beta (5Y Monthly)||2.39|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||23.40|
A new fiscal year is underway for Canopy Growth (NYSE: CGC) -- one that will be full of work and transition, per the company's new CEO David Klein. In Q1, Canopy Growth's net revenue of 110.4 million Canadian dollars was up 22% year over year. Without stronger sales numbers, it may be difficult for growth investors to buy the stock.
Last year, marijuana investors still would have likely considered cannabis companies Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) to be the industry leaders in the Canadian pot market. Although Aphria was a big name in the cannabis industry a year ago, investors weren't considering it in the same breath as Aurora or Canopy Growth. A year ago, Aphria's market cap was about $1.6 billion, nowhere near Aurora's $8 billion valuation or Canopy Growth's astronomical market cap of over $10 billion.
Green Thumb Industries CEO & Founder Ben Kovler joins Yahoo Finance's Zack Guzman to discuss the cannabis company's latest earnings results amid the coronavirus pandemic.